The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCES INC | COM | 00032Q104 | 4,327,601 | 1,849,402 | SH | SOLE | 1,849,402 | 0 | 0 | |||
AGIOS PHARMA | COM | 00847X104 | 1,615,861 | 55,262 | SH | SOLE | 55,262 | 0 | 0 | |||
APPLIED THERAPEUTICS INC | COM | 03828A101 | 5,385,600 | 792,000 | SH | SOLE | 792,000 | 0 | 0 | |||
ARCELLX INC | COMMON STOCK | 03940C100 | 2,399,475 | 34,500 | SH | SOLE | 34,500 | 0 | 0 | |||
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 4,574,730 | 109,000 | SH | SOLE | 109,000 | 0 | 0 | |||
CELLECTAR BIOSCIENCES INC. | COM NEW | 15117F807 | 571,130 | 143,500 | SH | SOLE | 143,500 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS | COM | 22663K107 | 3,670,044 | 78,403 | SH | SOLE | 78,403 | 0 | 0 | |||
DISC MEDICINE INC | COM | 254604101 | 4,781,568 | 76,800 | SH | SOLE | 76,800 | 0 | 0 | |||
DYNE THERAPEUTICS INC | COM | 26818M108 | 5,237,955 | 184,500 | SH | SOLE | 184,500 | 0 | 0 | |||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 6,967,381 | 396,099 | SH | SOLE | 396,099 | 0 | 0 | |||
HILLEVAX INC | COM | 43157M102 | 4,167,628 | 250,609 | SH | SOLE | 250,609 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 2,983,699 | 92,346 | SH | SOLE | 92,346 | 0 | 0 | |||
INSMED INC | COM PAR $.01 | 457669307 | 1,674,409 | 61,718 | SH | SOLE | 61,718 | 0 | 0 | |||
INTRA-CELLULAR THERAPIES INC. | COM | 46116X101 | 920,360 | 13,300 | SH | SOLE | 13,300 | 0 | 0 | |||
KURA ONCOLOGY INC. | COM | 50127T109 | 1,919,700 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | |||
LEAP THERAPEUTICS INC | COM NEW | 52187K200 | 942,082 | 354,166 | SH | SOLE | 354,166 | 0 | 0 | |||
LYRA THERAPEUTICS INC | COM | 55234L105 | 1,078,050 | 173,320 | SH | SOLE | 173,320 | 0 | 0 | |||
MEREO BIOPHARMA GROUP PLC | SPON ADS | 589492107 | 1,313,017 | 397,884 | SH | SOLE | 397,884 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 9,697,533 | 2,164,628 | SH | SOLE | 2,164,628 | 0 | 0 | |||
NUVATION BIO | *W EXP 07/07/2027 | 67080N119 | 27,477 | 90,832 | SH | SOLE | 90,832 | 0 | 0 | |||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 23,981,112 | 2,635,287 | SH | SOLE | 2,635,287 | 0 | 0 | |||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 1,429,890 | 103,992 | SH | SOLE | 103,992 | 0 | 0 | |||
PRAXIS PRECISION MEDICINES I | COM | 74006W207 | 9,903,668 | 162,302 | SH | SOLE | 162,302 | 0 | 0 | |||
REVOLUTION MEDICINES INC | COM | 76155X100 | 4,633,933 | 143,777 | SH | SOLE | 143,777 | 0 | 0 | |||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 8,803,642 | 326,787 | SH | SOLE | 326,787 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 8,306,413 | 64,162 | SH | SOLE | 64,162 | 0 | 0 | |||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 9,566,666 | 3,333,333 | SH | SOLE | 3,333,333 | 0 | 0 | |||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 3,050,918 | 465,079 | SH | SOLE | 465,079 | 0 | 0 | |||
TOURMALINE BIO INC | COM | 89157D105 | 5,979,373 | 261,108 | SH | SOLE | 261,108 | 0 | 0 | |||
ULTRAGENYX PHARMACEUTICAL INC | COM | 90400D108 | 933,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 7,160,937 | 104,830 | SH | SOLE | 104,830 | 0 | 0 | |||
VERASTEM INC | COM NEW | 92337C203 | 2,443,721 | 207,095 | SH | SOLE | 207,095 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 3,492,072 | 199,433 | SH | SOLE | 199,433 | 0 | 0 |